Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Little Urban areas to Visit in Western Europe- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
- Top 10 Moving Style Architects of the Year
- The most exciting exoplanet discoveries of 2025
- Which sandwich do you find totally delectable? !
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- Best Exciting ride: Which One Rushes You the Most?
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- Figure out How to Reveal Stowed away Open Record Rewards
